These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10211105)

  • 21. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New developments in radiotherapy of head and neck cancer: higher precision with less patient discomfort?
    Langendijk JA
    Radiother Oncol; 2007 Oct; 85(1):1-6. PubMed ID: 17854932
    [No Abstract]   [Full Text] [Related]  

  • 23. Aspiration as a late complication after accelerated versus conventional radiotherapy in patients with head and neck cancer.
    Lindblom U; Nilsson P; Gärskog O; Kjellen E; Laurell G; Wahlberg P; Zackrisson B; Levring Jäghagen E
    Acta Otolaryngol; 2016; 136(3):304-11. PubMed ID: 26838580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on oxygen partial pressure in tumor tissue under radiotherapy and thermoradiotherapy].
    Füller J; Feldmann HJ; Molls M; Sack H
    Strahlenther Onkol; 1994 Aug; 170(8):453-60. PubMed ID: 8085211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer: in regard to Chen et al. (Int J Radiat Oncol Biol Phys. 2010 Jul 23).
    Salem A; Al-Rashdan A; Abu-Hijle F; Khader J; Hashem S; Almousa A
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):640; author reply 640. PubMed ID: 21549253
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of head and neck cancer with twice-a-day fractionation].
    Nishiyama K
    Gan No Rinsho; 1988 Oct; 34(13):1783-7. PubMed ID: 3199514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiences with afterloading irradiation of malignant head and neck tumors].
    von Scheel J; Koch K
    Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):329-31. PubMed ID: 3626716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy for head and neck cancer.
    Schwartz DL; Garden AS
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):259-85. PubMed ID: 16730295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
    Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
    Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic gain factor of multiple fractions per day].
    Kanehira C; Mochizuki S
    Gan No Rinsho; 1988 Oct; 34(13):1757-63. PubMed ID: 3199511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Need for objective patient selection criteria for palliative radiotherapy in advanced head and neck cancer.
    Chilukuri S; Laskar SG; Murthy V; Agarwal JP; Budrukkar A; Dinshaw KA
    Radiother Oncol; 2008 May; 87(2):308; author reply 309. PubMed ID: 18417233
    [No Abstract]   [Full Text] [Related]  

  • 32. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.
    Zajusz A; Maciejewski B; Hliniak A
    Neoplasma; 1995; 42(3):137-40. PubMed ID: 7637824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
    Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
    Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In regard to Lee et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. (Int J Radiat Oncol Biol Phys 2003;57:49-60).
    Yao M; Dornfeld KJ; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1639; author reply 1639-40. PubMed ID: 15050350
    [No Abstract]   [Full Text] [Related]  

  • 36. Accelerated fractionation: what is the price for speeding?
    Ang KK
    Radiother Oncol; 1997 Aug; 44(2):97-9. PubMed ID: 9288837
    [No Abstract]   [Full Text] [Related]  

  • 37. Advances in radiotherapy for carcinoma of the head and neck.
    Morris MM; Schmidt-Ullrich R; Johnson CR
    Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comments on ocular globe topography in Radiotherapy by Karlsson et al. IJROBP 33(3):705-712;1995.
    Wong G; Burleson WD; Hogrefe P
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):635. PubMed ID: 8655393
    [No Abstract]   [Full Text] [Related]  

  • 39. An 'elegant' radiotherapy comes of age.
    Kirn TF
    JAMA; 1987 Dec; 258(22):3217,3219-20. PubMed ID: 3682108
    [No Abstract]   [Full Text] [Related]  

  • 40. Will altered fraction schemes alter the future?
    Cooper JS
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1621-2. PubMed ID: 2262388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.